Publications by authors named "B Chabner"
Background: Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin's lymphoma worldwide and particularly in Africa, where the incidence of HIV is the highest in the world. R-CHOP is the standard of care regimen for DLBCL, but access to rituximab is limited in developing countries.
Methods: This is a retrospective cohort study that included all HIV-negative patients with DLBCL who received R-CHOP at a single institution from January 2012 to December 2017.
Article Synopsis
- In cases where cancer is involved, deciding whether to continue or end a pregnancy can be really hard.
- This editorial talks about how recent changes in the law affect cancer patients facing this tough choice.
- The Oncologist team wants to help people understand what these legal changes mean for patients with cancer.
The past and future Editors-in-Chief of The Oncologist offer thoughts on the recent U.S. Supreme Court leak and its significance for other areas of medical practice.
View Article and Find Full Text PDFPurpose: Cancer clinical trial (CCT) participants are at risk for experiencing adverse associations from financial toxicity, but these remain understudied.
Methods: From July 2015 to July 2017, we prospectively enrolled CCT participants referred for financial assistance and a group of patients matched by age, sex, cancer type, trial, and trial phase. We assessed financial burden of cancer care, cost concerns about CCTs, physical (Edmonton Symptom Assessment Scale [ESAS]) and psychologic (Patient Health Questionnaire-4 [PHQ-4]) symptoms, illness perceptions (Brief Illness Perception Questionnaire), and communication confidence (Perceived Efficacy in Patient-Physician Interactions).